Physician profile
Emile Bacha
NPI 1396856159
$51,473.70
in general payments reported to CMS, 2019-2025
7 companies · $31K in 2025
The $31K reported for 2025 was more than what 95% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $87.50 · 2021: $1,304 · 2022: $1,717 · 2023: $2,054 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $28K · Food and Beverage: $3,390 · Grant: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $27,700.00 |
| Food and Beverage | $3,390.22 |
| Grant | $1,494.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $30,434.84 | 2019-2025 | |
| Elutia, INC. | $11,128.33 | 2019-2023 | |
| Artivion, INC. | $6,317.20 | 2019-2025 | Cardiac Non-Synergraft, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Photofix Decellularized Bovine Pericardium |
| Medtronic, INC. | $3,169.51 | 2022-2023 | |
| Abbott Laboratories | $357.68 | 2023-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Lemaitre Vascular, INC. | $66.14 | 2023 | Tyke, Patch, Pledget and Intracardiac, Cardiocel |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emile Bacha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.